Clinical trial Recruiting at 1 site Observational Ages 40 and up

Examining health literacy and quality of life in COPD patients

Official title: An Investigation of Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in Chronic Obstructive Pulmonary Disease and Healthy Individuals

Run by Hacettepe University · NCT06497816 · Data updated 2026-11-12

This study looks at how understanding health information affects the quality of life and daily activities of people with COPD compared to healthy individuals over 40.

More COPD trials

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment144 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara, Ankara)
StatusRecruiting
StartedJune 15, 2024
Main results expectedJune 15, 2027
Study endsJune 15, 2027
Registry record updatedJune 25, 2026
Trial IDNCT06497816 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals over 40 years old who have a stable diagnosis of COPD and are willing to participate.

Probably not a fit

Patients experiencing acute exacerbations of COPD or those with cardiovascular, orthopedic, or neurological issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between health literacy and various factors such as functional capacity, quality of life, physical activity, cognitive function, and health-related behaviors in individuals diagnosed with chronic obstructive pulmonary disease (COPD). The study will compare these aspects between COPD patients and healthy individuals over the age of 40. By assessing these relationships, the research seeks to highlight the importance of health literacy in managing COPD and improving overall well-being.

Why it matters

Potential benefit: If successful, this study could enhance understanding of how health literacy impacts the quality of life and functional capacity in COPD patients, leading to better management strategies.

How similar studies have gone: While studies on health literacy in chronic diseases exist, this specific focus on COPD and its multifaceted relationships is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria for the COPD group:

* Being over 40 years old,
* Diagnosed with COPD and being clinically stable,
* Being able to cooperate with the tests to be performed,
* Not having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
* Being willing to participate in the study.

Exclusion criteria for the COPD group:

* Being in an acute exacerbation period,
* Having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
* Not being willing to participate in the study.

Inclusion criteria for the control group:

* Being willing to participate in the study and being over 40 years old
* Not having any known disease

Exclusion criteria for the control group:

* Not being able to cooperate with the tests to be performed
* Not being willing to participate in the study

Where it's running

  • Hacettepe University Faculty of Physical Therapy and Rehabilitation
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.